June 2023 Price Concessions Final Update
THIS CONTENT HAS NOW EXPIRED
Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners (our members), the Department has today (30/06/2023) announced the following list of final price concessions for June 2023:
| Drug | Pack size | Price concession |
| * Alginate raft-forming oral suspension sugar free | 500 | £3.80 |
| Amiloride 5mg tablets | 28 | £13.46 |
| Amoxicillin 125mg/5ml oral suspension sugar free | 100 | £2.68 |
| Benzoyl peroxide 5% / Clindamycin 1% gel | 60 | £22.22 |
| Buprenorphine 8mg sublingual tablets sugar free | 7 | £11.36 |
| Calamine lotion | 200 | £1.86 |
| Chloramphenicol 0.5% eye drops | 10 | £12.51 |
| Chlorphenamine 2mg/5ml oral solution sugar free | 150 | £4.01 |
| Clotrimazole 500mg pessary and Clotrimazole 2% cream | 1 | £10.79 |
| Co-careldopa 12.5mg/50mg tablets | 90 | £4.93 |
| Co-trimoxazole 80mg/400mg tablets | 28 | £2.34 |
| Docusate 50mg/5ml oral solution sugar free | 300 | £18.81 |
| Flucloxacillin 250mg capsules | 28 | £2.45 |
| Isoniazid 100mg tablets | 28 | £60.00 |
| Ivabradine 5mg tablets | 56 | £28.33 |
| Letrozole 2.5mg tablets | 14 | £6.66 |
| Methylphenidate 5mg tablets | 30 | £3.45 |
| Mometasone 0.1% cream | 30 | £3.60 |
| Mycophenolate mofetil 500mg tablets | 50 | £7.69 |
| Pantoprazole 20mg gastro-resistant tablets | 28 | £6.62 |
| Pantoprazole 40mg gastro-resistant tablets | 28 | £9.23 |
| Paracetamol 500mg effervescent tablets | 100 | £10.34 |
| Pregabalin 300mg capsules | 56 | £4.02 |
| Promethazine hydrochloride 25mg tablets | 56 | £29.32 |
| Quinine sulfate 200mg tablets | 28 | £7.97 |
| Risperidone 500microgram tablets | 20 | £2.98 |
| Rosuvastatin 20mg tablets | 28 | £4.98 |
| Sodium chloride 0.9% nebuliser liquid 2.5ml unit dose ampoules | 20 | £11.04 |
| Tacrolimus 0.1% ointment | 60 | £41.69 |
| Tacrolimus 0.1% ointment | 30 | £22.36 |
| Tamsulosin 400microgram / Dutasteride 500microgram capsules | 30 | £14.53 |
| Tolterodine 2mg tablets | 56 | £3.55 |
| Topiramate 100mg tablets | 60 | £16.53 |
| Tramadol 37.5mg / Paracetamol 325mg tablets | 60 | £7.38 |
| Trazodone 50mg capsules | 84 | £3.45 |
| Venlafaxine 75mg tablets | 56 | £11.51 |
| Zolmitriptan 2.5mg tablets | 6 | £18.85 |
| Zolmitriptan 2.5mg tablets | 12 | £37.70 |
Products in italics were rolled over from May 2023 but have subsequently received a higher price for June 2023.
* The Department of Health and Social Care has agreed that the following concessionary price granted in June 2023 will be rolled over for July 2023:
- Alginate raft-forming oral suspension sugar free 500 £3.80
For the full list of price concessions granted for June 2023, please visit our webpage: cpe.org.uk/priceconcessions
No additional endorsements are required for price concessions. A price concession only applies for the month it is granted; any prices agreed for concessions requested late in the month will roll over into the following month.
We encourage pharmacies to report any problems obtaining a Part VIII product at or below the stated Drug Tariff price, using the online feedback form on the Community Pharmacy England website. Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. We will investigate the extent of the problem and, if appropriate, discuss the issue with DHSC.
Please subscribe to our mailing list to receive email updates of any price concessions.
Further information on price concessions and FAQs about the process involved can be found on our website (cpe.org.uk/priceconcessions) To hear more on how the current price concessions system operates, pharmacy teams can now access a recording of our recent webinar here.
Improvements to the price concession system
Following significant concerns raised by pharmacies about the unsustainable level of prices imposed by DHSC in second half of 2022, it was agreed that an urgent review of the price concession setting system would take place.
Since this announcement, we have sent a strong and clear message back to Government that pharmacies cannot continue to subsidise the NHS medicines bill. Following the review of the concessionary price process, a package of measures has been developed to improve the system.
One of the solutions agreed between us and DHSC is that from 1st April 2023, all products granted a concessionary price will be classified as ‘Discount Not Deducted’ for the month(s) in which they are on concession.
Furthermore, from May 2023, DHSC has implemented a process to roll over prices to the following month for any concessions requested after the 23rd of the month provided these prices were agreed with us. We are also continuing to work with DHSC on how a ‘retrospective increased payment’ my apply, when appropriate. Further information regarding this concession ‘top-up’ mechanism will be issued once details are finalised.
